The Ubiquitin Specific Peptidase 22 (USP22) is a deubiquitinating enzyme that was identified as a member of an 11 gene “death-from-cancer” signature which correlates with cancer stem cell characteristics and predicts disease recurrence, metastasis, and poor response to therapy in malignancies of various origins including BC [6]. This evidence concerns the gene USP22 and cancer.